SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!

Detalles Bibliográficos
Autores principales: DULU, ALINA, PASTORES, STEPHEN, SILVEY, KATHERINE, TAYBAN, KATE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Critical Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503143/
http://dx.doi.org/10.1016/j.chest.2021.07.644
_version_ 1784581048442552320
author DULU, ALINA
PASTORES, STEPHEN
SILVEY, KATHERINE
TAYBAN, KATE
author_facet DULU, ALINA
PASTORES, STEPHEN
SILVEY, KATHERINE
TAYBAN, KATE
author_sort DULU, ALINA
collection PubMed
description
format Online
Article
Text
id pubmed-8503143
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85031432021-10-12 SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL! DULU, ALINA PASTORES, STEPHEN SILVEY, KATHERINE TAYBAN, KATE Chest Critical Care American College of Chest Physicians. Published by Elsevier Inc. 2021-10 2021-10-11 /pmc/articles/PMC8503143/ http://dx.doi.org/10.1016/j.chest.2021.07.644 Text en Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Critical Care
DULU, ALINA
PASTORES, STEPHEN
SILVEY, KATHERINE
TAYBAN, KATE
SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!
title SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!
title_full SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!
title_fullStr SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!
title_full_unstemmed SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!
title_short SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!
title_sort severe refractory immune thrombocytopenia in an oncology patient with covid-19: rare but fatal!
topic Critical Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503143/
http://dx.doi.org/10.1016/j.chest.2021.07.644
work_keys_str_mv AT dulualina severerefractoryimmunethrombocytopeniainanoncologypatientwithcovid19rarebutfatal
AT pastoresstephen severerefractoryimmunethrombocytopeniainanoncologypatientwithcovid19rarebutfatal
AT silveykatherine severerefractoryimmunethrombocytopeniainanoncologypatientwithcovid19rarebutfatal
AT taybankate severerefractoryimmunethrombocytopeniainanoncologypatientwithcovid19rarebutfatal

Ejemplares similares